JAN (NYSE:JAN) Stock Gets Downgrade from Zacks Research

JAN (NYSE:JAN) was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued on Tuesday, Zacks reports.

A number of other research analysts have also weighed in on the stock. Wells Fargo & Company reduced their price objective on shares of JAN from $35.00 to $34.00 and set an “overweight” rating for the company in a research note on Monday. Weiss Ratings started coverage on JAN in a research report on Thursday, August 6th. They set a “hold (c-)” rating on the stock. Wall Street Zen raised JAN from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. JPMorgan Chase & Co. lifted their price target on JAN from $30.00 to $34.00 and gave the company an “overweight” rating in a research report on Tuesday, August 18th. Finally, Barclays reduced their price target on JAN from $34.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, JAN presently has a consensus rating of “Moderate Buy” and an average target price of $32.31.

JAN Trading Down 3.1%

Shares of NYSE:JAN opened at $28.32 on Tuesday. The company has a 50-day moving average price of $30.00 and a two-hundred day moving average price of $28.27. JAN has a twelve month low of $22.76 and a twelve month high of $32.83.

JAN (NYSE:JAN) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.18). The firm had revenue of $216.46 million for the quarter, compared to the consensus estimate of $203.32 million. The business’s revenue for the quarter was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. As a group, sell-side analysts anticipate that JAN will post 0.97 EPS for the current fiscal year.

Institutional Trading of JAN

Several institutional investors and hedge funds have recently bought and sold shares of JAN. Nisa Investment Advisors LLC bought a new position in JAN in the 3rd quarter valued at $27,000. Greenland Capital Management LP purchased a new position in shares of JAN during the 2nd quarter valued at $575,000. Sumitomo Mitsui DS Asset Management Company Ltd bought a new position in shares of JAN in the third quarter worth $627,000. State of Alaska Department of Revenue increased its holdings in shares of JAN by 57.6% in the third quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock worth $1,082,000 after purchasing an additional 13,367 shares during the period. Finally, Readystate Asset Management LP bought a new position in shares of JAN in the second quarter worth $1,724,000. 6.27% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: The most relevant available fundamental backdrop remains JAN’s latest quarterly report: earnings of $0.05 per share missed the $0.23 analyst consensus, although revenue of $216.46 million exceeded estimates and increased 45.4% year over year. Management maintained fiscal 2026 EPS guidance of $0.95 to $0.98, which may provide some support but does not eliminate concerns about profitability and the earnings shortfall.

About JAN

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.